http://www.acc.org/Feed?clinicalTopicID=277d44d1-8fe9-4754-b6e3-a30df1945db7 Clinical Topic Feed: Statins en /Latest-in-Cardiology/Articles/2026/08/24/12/30/sat-215am-staree-esc-2026 Among community-dwelling older adults, treatment with atorvastatin demonstrated a 30% relative reduction in major cardiovascular events over roughly six years compared with placebo but did not result in longer disability-free survival, based on findings from the STAREE trial presented at ESC Congress 2026 and simultaneously published in NEJM. 1787991840000 Articles and Stories /Latest-in-Cardiology/Articles/2026/08/17/15/29/A-Rare-Pattern-of-Harm Statin therapy remains a cornerstone in the prevention of cardiovascular (CV) morbidity and mortality. Although statin-associated muscle symptoms are relatively common and often self-limited, severe statin-associated immune-mediated necrotizing myopathy (IMNM) has emerged as a rare but important clinical entity. 1786989360000 Articles and Stories /Latest-in-Cardiology/Articles/2026/08/03/15/28/Cardiotoxicity-Risk Immune checkpoint inhibitors (ICIs) are revolutionary oncologic therapies used frontline in several malignant neoplasms, including non–small cell lung cancer, melanoma, renal cell carcinoma, bladder cancer, and colorectal cancer. 1785780720000 Articles and Stories /Latest-in-Cardiology/Articles/2026/05/27/15/57/eagles-eye-view-27may2026 In this week’s View, Dr. Eagle examines recent research into maintaining weight loss with tirzepatide. He then offers insights into the new dyslipidemia guidelines, including addressing reproductive and hormone risk factors in cardiovascular risk assessment. 1779898740000 Articles and Stories /Latest-in-Cardiology/Articles/2026/05/19/15/49/JACC-Spotlight-Issue-2026-Dyslipidemia-Guideline A special JACC Spotlight Issue supporting the recently published 2026 ACC/AHA Guideline on the Management of Dyslipidemia, offers commentaries that provide a comprehensive overview of the new guideline recommendations and expert insights into understanding the science behind the recommendations... 1779206040000 Articles and Stories /Latest-in-Cardiology/Articles/2026/05/01/01/Journal-Wrap The hottest research from various peer-reviewed journals – handpicked weekly by the ACC. 1777637340000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/01/01/Journal-Wrap The hottest research from various peer-reviewed journals – handpicked weekly by the ACC. 1775045400000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/25/21/27/sat-345pm-vesaliuscv-acc-2026 The PCSK9 inhibitor evolocumab reduced the risk of a first major cardiovascular event in patients with diabetes without known significant atherosclerosis, according to a prespecified subgroup analysis of the VESALIUS-CV trial, presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans and simultaneously published in JAMA. 1774730760000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/18/00/50/eagles-eye-view-18mar2025 In this week’s View, Dr. Eagle looks at data from the STS/ACC TVT Registry on off label transcatheter valve interventions that demonstrate reduced residual tricuspid regurgitation (TR) and improved quality of life. 1773842400000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/03/13/15/20/ACC-AHA-Release-New-Clinical-Guideline-For-Managing-Dyslipidemia The new ACC/AHA Guideline on the Management of Dyslipidemia offers a comprehensive “one-stop shop” for addressing the evaluation, management and monitoring of individuals with dyslipidemias, including high blood cholesterol, hypertriglyceridemia, and elevated lipoprotein(a) (Lp[a]). 1773415860000 Articles and Stories